📢Adjuvant imatinib in high risk GIST:
3 years or 6years?

IMADGIST ESMO - Eur. Oncology Virtual Plenary, Annals of Oncology

✅DFS was significantly superior with 6-year imatinib
HR: 0.40 [0.20-0.69], p=0.0008

➡️136 patients
➡️Localized GIST with KIT expression, a R0 or R1 surgery, and a…

Depending on the magnitude of benefit seen in #DB06 , there is a chance that T-DXd may start to be used as 1L for patients with endocrine-refractory HR+/HER2- (low/ultralow) MBC.

Assuming all available, which 2L would you consider at progression on T-DXd?

📢 #OncTwitter - Don't miss the 2024 Upstate NY Cancer Symposium!

💬 The latest in breast, lung, GU, & GI cancers + more!

📅 June 29-30
📍 Rochester, NY
🗣️ Moderated by Oncology Brothers
✍️ Register: bit.ly/3STkkUc

Roswell Park Wilmot Cancer Institute #MedEd #FOAMed #UpstateCancer

Tune into Oncology Brothers below for IR vs. rad onc in HCC -the boxing gloves were out!

Just kidding. We didn't get into studies in detail given time constraints, but I generally consider this framework for liver-confined HCC:

-Small tumor (<~3 cm), favorable location – several…

#HemeSeries : This is the #Algorithm we have used during our discussion w/ Caitlin Costello, MD for Newly Diagnosed #MultipleMyeloma

-Relapsed/Refractory #Myeloma discussion w/ Samer Al Hadidi, MD,MS,FACP to follow.

#HemeTwitter #OncTwitter #MedTwtitter #mmsm #MedEd CancerNetwork® #OncEd OncoAlert

Really enjoyed this discussion with Oncology Brothers regarding practical approaches to the patient with newly diagnosed multiple myeloma. UC San Diego Health Moores Cancer Center CancerNetwork® #mmsm

#HemeSeries : w/ Caitlin Costello, MD to discuss Rx options for Newly Diagnosed #MultipleMyeloma

Full discussion:
- cancernetwork.com/treatment-algo…
- Oncbrothers.com/newmyeloma-alg…
- Also on the “Oncology Brothers” podcast

#HemeTwitter #MedTwitter #OncTwitter CancerNetwork® #MMsm

1/ 🔥Our 🆕 Clinical Lung Cancer Brief Report on 1L testing & management in mNSCLC is out! With multiple frontline treatments, it's a complex landscape!

Enjoyed collaborating w/ mentee Arthi Sridhar & mentor H. Jack West, MD.

Key insights👇🏽, a 🧵: ⁦OncoAlert⁩ sciencedirect.com/science/articl…

Bijoy Telivala Oncology Brothers Arthi Sridhar Ivy Riano, M.D. Arpan Patel Patrick Forde ASCO Aakash Desai, MD, MPH H. Jack West, MD Narjust Florez, MD, FASCO Bruna Pellini, MD Dr. Estela Rodriguez Misty Dawn Shields Brendon Stiles Santhosh Ambika Agree! This is tough. If there is an option to enroll on perioperative trial (eg NAUTIKA1 etc), I would try for that! Otherwise, thinking about the biology and response that we see to ICI in stage 4 dz for select biomarkers, warrants very nuanced & shared decision making

Improved survival benefits w/ ICIs & targeted therapies in metastatic #NSCLC have led to these agents being used in early-stage NSCLC. Oncology Brothers, Arthi Sridhar, Arpan Patel & Ivy Riano, M.D. explore the current treatment landscape: brnw.ch/21wJs8D #LCSM #ASCODailyNews

Treatment landscape for resectable NSCLS is quickly changing. Discussion/group effort by led Arthi Sridhar Ivy Riano, M.D. Arpan Patel to reiterate the current SoC!

Patrick Forde thank you for ICER table! 🙏🏽🙏🏽

#lcsm #ASCODailyNews ASCO #OncTwitter #ASCO24 #MedTwitter

82 M ecog 2 CLL- Rai StgIV. p53 unmutated
GFR 20
Progressed on R-Benda/Ibrutnib/Rev/Venclexta/Calquence/Pitro
He even got R miniCHOP- there was a concern for ?Richters
Cant get car-T
I am scared of using idelasib
Options if any?
Nitin Jain Alan Skarbnik Oncology Brothers

So excited to be part of this amazing program organized by Oncology Brothers at ASCO #ASCO24 #BreastCancer Ohio State Medical Oncology The James The Ohio State University Wexner Medical Center #bcsm

Ten important observations about myeloma and its precursors that I often discuss with patients and teach to trainees in my clinic.

An educational thread

🧵

#mmsm

1/

Had a wonderful time discussing CLL Rx paradigm with Oncology Brothers 🙏🏽🙏🏽👏👏

#HemeSeries : This is the #Algorithm we have used during our discussion w/ Nitin Jain for #CLL

#HemeTwitter #OncTwitter #MedTwtitter #leusm #MedEd CancerNetwork® #OncEd OncoAlert Hem-Onc Fellows Network

The next installment of the Treatment Algorithm series is here! Catch the Oncology Brothers and Nitin Jain discussing #CLL . Watch the full series here 🔽
cancernetwork.com/treatment-algo…